Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Operating Income Loss of $25.16 million for the year ending 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -88.9% in Operating Income Loss from 2024 to 2025.
- This data is from CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s annual report (Form 10-K), filed with the SEC on February 18, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s Operating Income Loss has grown by 105.6%.
- Historical annual values: Fiscal year 2025: $25.16 million | Fiscal year 2024: $227.35 million | Fiscal year 2023: $617.26 million | Fiscal year 2022: $650.98 million | Fiscal year 2021: $589.86 million | Fiscal year 2020: $432.73 million | Fiscal year 2019: $351.15 million | Fiscal year 2018: $331.38 million | Fiscal year 2017: $288.28 million | Fiscal year 2016: $237.55 million | Fiscal year 2015: $206.45 million | Fiscal year 2014: $177.67 million | Fiscal year 2013: $151.40 million | Fiscal year 2012: $165.77 million | Fiscal year 2011: $174.31 million | Fiscal year 2010: -$298.51 million | Fiscal year 2009: $169.61 million | Fiscal year 2008: -$451.84 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: